v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 3,049 $ 2,897 $ 7,170 $ 6,628
Cost of revenue 1,242 1,084 2,836 2,919
Gross profit 1,807 1,813 4,334 3,709
Operating expenses:        
Sales and marketing 1,685 1,740 5,265 5,972
Research and development 618 599 1,930 1,762
General and administrative 2,293 1,706 6,415 5,836
Impairment of goodwill 0 189 0 189
Restructuring 0 0 0 244
Total operating expenses 4,596 4,234 13,610 14,003
Loss from operations (2,789) (2,421) (9,276) (10,294)
Other income (expense), net:        
Interest expense (24) (23) (77) (113)
Gain (loss) on revaluation of warrant liabilities 1,125 4,476 2,011 (1,579)
Warrant issuance expense 0 0 0 (329)
Gain on forgiveness of note payable 0 0 1,099 0
Other (expense) income, net (270) 420 (658) 466
Total other income (expense), net 831 4,873 2,375 (1,555)
Net (loss) income (1,958) 2,452 (6,901) (11,849)
Other comprehensive income (loss) 261 (415) 601 (435)
Comprehensive (loss) income $ (1,697) $ 2,037 $ (6,300) $ (12,284)
Net (loss) income per share applicable to common shareholders, basic (in dollars per share) $ (0.15) $ 0.30 $ (0.57) $ (1.75)
Net loss per share applicable to common shareholders, diluted (in dollars per share) $ (0.17) $ (0.01) $ (0.62) $ (1.78)
Weighted average number of shares outstanding, basic (in shares) 12,661 8,236 12,029 6,772
Weighted average number of shares outstanding, diluted (in shares) 12,710 8,379 12,133 6,829

Source